On November 4, REMEGEN recorded an Intraday Rise of 5.52% in Regular Trading, with shares trading at HK$65.95 and turnover of HK$65.66 million.
The clearest catalyst in recent disclosures is the company’s plan to repurchase A shares for RMB30 million to RMB60 million, a move aimed at safeguarding corporate value and shareholder interests and helping lift market sentiment.
Company filings show the buyback price cap is RMB131 per share, and the new plan is the second A-share repurchase program launched this year. The proposal came after the company’s A shares had fallen more than 20% over the prior 20 trading days. Separately, progress on the first buyback indicates about 60,040 A shares had been repurchased by October 31 for roughly RMB6.63 million. Recent support also includes stronger fundamentals disclosed on October 29, when the company reported first-nine-month revenue of RMB6.764 billion, up 293.28%, and net profit attributable to shareholders of RMB5.273 billion, versus a loss a year earlier.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments